Paul Dent, Ph.D., Steven Grant, M.D., Mohamed Rahmani, Ph.D., John Roberts, M.D.

Location: VCU Massey Cancer Center - Virginia

Proposal: Reestablishing the leukemia cell death program with sorafenib and Bcl-2 antagonists